Form 4: American Healthcare REIT Director Brian J. Flornes Receives Restricted Stock Grant Upon Re-election

American Healthcare REIT, Inc. director Brian J. Flornes was granted 3,042 shares of restricted common stock following his re-election to the board, with the shares vesting in one year.

Summary

• Brian J. Flornes, a Director of American Healthcare REIT, Inc. (AHR), was re-elected to the company's board of directors.
• Upon his re-election on June 25, 2025, Mr. Flornes was granted 3,042 shares of restricted common stock.
• The acquisition price for these shares was $0, indicating a grant rather than a purchase.
• Following this transaction, Mr. Flornes beneficially owns a total of 30,426 shares of common stock.
• The newly granted restricted shares are scheduled to vest on June 25, 2026.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive as it reflects routine corporate governance and compensation practices that align director interests with shareholders, without indicating any negative operational or financial news.

Positives

• The grant of restricted stock to Director Brian J. Flornes aligns his interests with those of the shareholders, as the value of his compensation is tied to the company's stock performance.
• The re-election of Mr. Flornes indicates continuity and stability in the company's board leadership.

Future Outlook

The 3,042 shares of restricted common stock granted to Director Brian J. Flornes are scheduled to vest on June 25, 2026, indicating a future milestone for this equity compensation.

Industry Context

This Form 4 filing represents a routine insider transaction related to director compensation, a common practice across various industries, including the healthcare REIT sector, to incentivize and retain board members.

Comparison to Industry Standards

• The grant of restricted stock as part of director compensation is a standard practice in corporate governance across publicly traded companies, including those in the REIT sector.
• The vesting schedule of one year for director equity grants is also a common structure designed to align long-term interests.

Management Changes

Corporate Governance

Related Party Transactions

• The grant of 3,042 shares of restricted common stock to Brian J. Flornes, a director, constitutes a related party transaction as it involves compensation from the company to a member of its board. This is a standard form of director remuneration.

Stakeholder Impact

• Shareholders: The grant of restricted stock aligns the director's financial incentives with shareholder interests, potentially encouraging decisions that enhance long-term stock value.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The 3,042 shares of restricted common stock granted to Brian J. Flornes will vest on June 25, 2026.

Key Dates

Keywords

American Healthcare REIT, AHR, SEC Form 4, Insider Transaction, Stock Grant, Director Compensation, Restricted Stock, Corporate Governance, Equity Compensation